Nervgen Pharma Quote - NGEN

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.72

Bid

2.70

Ask

2.74

Volume

10,201

2.72 Day's Range 2.77

0.00 52 Week Range 0.00

Market Cap

162.128M

Previous Close

2.74

Open

2.74

Last Trade

100

2.72

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

59,606,000

Dividend Yield

PE Ratio

-7.24

Earnings Per Share (EPS)

-0.38

Revenue

Net Profit

-22.38M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.nervgen.com

Headquarters

Vancouver, British Columbia, Can

Founded

Nervgen Pharma Corporation is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker NGEN. The last closing price for Nervgen Pharma was $2.74. Over the last year, Nervgen Pharma shares have traded in a share price range of $ 0.00 to $ 0.00.

Nervgen Pharma currently has 59,606,000 shares outstanding. The market capitalization of Nervgen Pharma is $163.32 million. Nervgen Pharma has a price to earnings ratio (PE ratio) of -7.24.

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - NGEN

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - NGEN Canada NewsWire VANCOUVER...

Canadian Investment Regulatory Organization Trade Resumption - NGEN

Canadian Investment Regulatory Organization Trade Resumption - NGEN Canada NewsWire VANCOUVER, BC, March 21, 2024 VANCOUVER, BC, March 21, 2024...

NERVGEN ANNOUNCES $20 MILLION BOUGHT DEAL OFFERING

NERVGEN ANNOUNCES $20 MILLION BOUGHT DEAL OFFERING Canada NewsWire VANCOUVER, BC, March 21, 2024 /NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE...

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NGEN

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NGEN Canada NewsWire VANCOUVER, BC...

Canadian Investment Regulatory Organization Trading Halt - NGEN

Canadian Investment Regulatory Organization Trading Halt - NGEN Canada NewsWire VANCOUVER, BC, March 21, 2024 VANCOUVER, BC, March 21, 2024 /CNW/...

Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies

For anyone with a spinal cord injury (SCI), time is of the essence. The typical treatment scenario involves immobilization and surgery as quickly...

Small Company Working on Big Breakthrough in Treating Spinal Cord Injuries

Spinal cord injuries (SCI) can be devastating, and they can lead to a loss of mobility, sensation, and independence. There is no cure for SCI, and...

Life Science Investor Forum Agenda Announced for June 22nd

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

NGEN - Frequently Asked Questions (FAQ)

What is the current Nervgen Pharma share price?

The current share price of Nervgen Pharma is $ 2.72

How many Nervgen Pharma shares are in issue?

Nervgen Pharma has 59,606,000 shares in issue

What is the market cap of Nervgen Pharma?

The market capitalisation of Nervgen Pharma is CAD 163.32M

What is the 1 year trading range for Nervgen Pharma share price?

Nervgen Pharma has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Nervgen Pharma?

The price to earnings ratio of Nervgen Pharma is -7.24

What is the reporting currency for Nervgen Pharma?

Nervgen Pharma reports financial results in CAD

What is the latest annual profit for Nervgen Pharma?

The latest annual profit of Nervgen Pharma is CAD -22.38M

What is the registered address of Nervgen Pharma?

The registered address for Nervgen Pharma is 1133 MELVILLE STREET, SUITE 3500, THE STACK, VANCOUVER, BRITISH COLUMBIA, V6E 4E5

What is the Nervgen Pharma website address?

The website address for Nervgen Pharma is www.nervgen.com

Which industry sector does Nervgen Pharma operate in?

Nervgen Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MOONBlue Moon Metals Inc	$ 3.00 (745.07%)	8.11k
TVITVI Pacific Inc	$ 0.015 (200.00%)	3.83M
KUR.HKure Technologies Inc	$ 0.10 (100.00%)	3k
FRAS.PFraser Big Sky Capital Corp	$ 0.20 (100.00%)	7.02k
ZENI.PZenith Captal Corporation	$ 0.10 (100.00%)	1,000
HCM.HHighcliff Metals Inc	$ 0.02 (-60.00%)	3k
OVL.HOlivier Ventures Inc	$ 0.01 (-60.00%)	58k
MPTH.HMapath Capital Corp	$ 0.015 (-50.00%)	1,000
ALMAlliance Mining Corp	$ 0.10 (-50.00%)	500
PTEPioneering Technology Corp	$ 0.01 (-50.00%)	9k
AFMAlphamin Resources Corp	$ 0.57 (23.91%)	5.31M
QNCQuantum Emotion Corp	$ 0.71 (26.79%)	4.66M
TRBETribe Property Technolgies Inc	$ 0.50 (4.17%)	3.97M
TVITVI Pacific Inc	$ 0.015 (200.00%)	3.83M
FMNFidelity Minerals Corporation	$ 0.025 (-28.57%)	3.05M